RGD Reference Report - Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.

Authors: Bolger, G  Lapeyre, N  Dansereau, N  Lagace, L  Berry, G  Klosowski, K  Mewhort, T  Liuzzi, M 
Citation: Bolger G, etal., Can J Physiol Pharmacol. 2005 Feb;83(2):198-213.
RGD ID: 4145715
Pubmed: PMID:15791294   (View Abstract at PubMed)
DOI: DOI:10.1139/y05-007   (Journal Full-text)

Intranasal infection of BALB/c mice with respiratory syncytial virus (RSV)-A2 (0.5 x 10(8) - 2.0 x 10(8) plaque-forming units, PFU) produced disease characterized by weight loss (2-3 g) and mortality (60%-100%) with the mean day of death ranging from 6-7 d after infection. The extent of RSV disease was inoculum titer-dependent and required a replication competent virus. Lung titers of virus peaked at 0.5-1 x 10(6) PFU/g wet weight. Bronchoalveolar lavage fluid (BALF) levels of IL-1beta, TNF-alpha, INF-gamma IL-12, IL-6, MIP-1alpha, RANTES, and protein were elevated, whereas IL-2, IL-4, IL-5, IL-13, and IL-10 were unchanged. Histological assessment of lungs revealed marked inflammatory pathology characterized by bronchiolitis, vasculitis, and interstitial pneumonia. Whole-body plethysmography revealed significant disease-associated deficits of respiratory function. Therapy with ribavirin administered either by the intranasal, subcutaneous, or oral route significantly reduced disease in a dose-dependent manner. Delaying the initiation of therapy resulted in a loss of activity for ribavirin. Synagis administered either intramuscularly as a single dose in prophylaxis or intranasally in prophylaxis, followed by therapy, also significantly reduced disease in a dose-dependent manner. Infection of mice with a high titer inoculum of RSV-A2 resulted in severe and fatal pulmonary disease that was responsive to treatment. This model may be useful to characterize the in vivo activity of experimental therapies for RSV infection.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
respiratory syncytial virus infectious disease  ISOTnf (Mus musculus)4145715; 4145715protein:increased expression:Bronchoalveolar lavage fluidRGD 
respiratory syncytial virus infectious disease  IEP 4145715protein:increased expression:Bronchoalveolar lavage fluidRGD 

Objects Annotated

Genes (Rattus norvegicus)
Tnf  (tumor necrosis factor)

Genes (Mus musculus)
Tnf  (tumor necrosis factor)

Genes (Homo sapiens)
TNF  (tumor necrosis factor)


Additional Information